Healthcare · Biotechnology
Price
$14.94
Market Cap
$911.1M
Employees
91
Beta
2.52
Avg Volume
1,103,492
CEO
David Alan Campbell
Business Description
Janux Therapeutics, Inc. is a biopharmaceutical company dedicated to developing innovative cancer therapies. The firm leverages its proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to create treatments designed to activate the body's T cells to fight tumors. Currently, Janux has several promising TRACTr product candidates in their early preclinical or discovery stages, which are engineered to target specific antigens such as prostate-specific membrane antigen, epidermal growth factor receptor, and trophoblast cell surface antigen 2. In addition to its TRACTr pipeline, the company is also developing a Tumor Activated Immunomodulator (TRACIr) — a costimulatory bispecific candidate designed to enhance T cell anti-tumor activity by engaging with programmed death-ligand 1 and CD28. Furthermore, a specific focus for their EGFR-TRACTr program is addressing epidermal growth factor receptor, a target prevalent in many cancer types and already a focus of numerous approved monoclonal antibody treatments. Janux Therapeutics, Inc. was founded in 2017 and is headquartered in La Jolla, California.
Business History
Price Overview
Last updated: Jun 27, 2026 10:06am (just now)$14.94
+0.36 (+2.47%)
Day Range
$14.45 – $15.44
52-Week Range
$12.12 – $35.34
50-Day MA
$14.38
200-Day MA
$17.82
Volume
3,239,885.00
Analyst Price Targets
Low
$14.00
Consensus
$23.83
High
$36.00
(23 analysts)
Share Structure
Outstanding
60,984,354.00
Float
57,261,424.00
Free Float
93.9%
High free float
— 93.9% of shares trade freely, ~6.1% held by insiders/institutions
Very liquid — most shares trade freely. Low insider ownership can mean less management alignment, but makes large position sizing straightforward.
Price History (1 Year)
Revenue & Net Income Trend
The directional story — useful even when net income is negative.
Revenue
The top line — total sales before any costs or taxes are subtracted. A measure of how much business the company is doing.
Net Income
The bottom line — profit left after subtracting all expenses, interest, and taxes from revenue. Reflects accounting profitability, but includes non-cash items like depreciation, so it isn't the same as cash earned.
Operating Cash Flow
The real cash generated by the day-to-day business — selling products, paying suppliers, collecting from customers. Calculated from net income by adding back non-cash items and adjusting for timing (unpaid bills, unsold inventory). When OCF consistently lags net income, the reported profit may not be converting to real money.
| Period | Revenue | Net Income | Net Margin | YoY/QoQ |
|---|
Key Metrics
API Direct from provider
CALC Derived from statements
P/E Ratio (Price per dollar of earnings)
CALCStock Price / EPS (Diluted)
-8.16
Stock Price: $14.94
EPS (Diluted): -1.83
EPS (Diluted): -1.83
P/B Ratio (Price vs net asset value)
APIStock Price / Book Value Per Share
0.89
Stock Price: $14.94
Total Equity: $956.82M
Shares: 61,966,999
Total Equity: $956.82M
Shares: 61,966,999
EV/EBITDA (Total value vs operating profit)
APIEnterprise Value / EBITDA
-7.83
Market Cap: $911.11M
Total Debt: $2.39M
Cash: $52.33M
EBITDA: -$111.60M
Total Debt: $2.39M
Cash: $52.33M
EBITDA: -$111.60M
Enterprise Value (Takeover price (cap + debt - cash))
APIMarket Cap + Total Debt - Cash
$824.9M
Market Cap: $911.11M
Total Debt: $2.39M
Cash: $52.33M
Total Debt: $2.39M
Cash: $52.33M
P/S Ratio (Price per dollar of revenue)
APIStock Price / Revenue Per Share
85.51
Stock Price: $14.94
Revenue: $10.00M
Shares: 61,966,999
Revenue: $10.00M
Shares: 61,966,999
EV/Sales (Total value vs revenue — works when P/E can't)
API82.49
Gross Margin (Revenue left after direct costs)
APIGross Profit / Revenue
79.7%
Gross Profit: $7.97M
Revenue: $10.00M
Revenue: $10.00M
Operating Margin (Revenue left after all operations)
APIOperating Income / Revenue
-1,576.7%
Operating Income: -$157.67M
Revenue: $10.00M
Revenue: $10.00M
Net Margin (Revenue left as actual profit)
APINet Income / Revenue
-1,136.3%
Net Income: -$113.63M
Revenue: $10.00M
Revenue: $10.00M
ROE (Profit from shareholder equity)
APINet Income / Total Equity
-11.8%
Net Income: -$113.63M
Total Equity: $956.82M
Total Equity: $956.82M
ROIC (Profit from all invested capital)
APINOPAT / Invested Capital
-16.2%
Operating Income: -$157.67M
Tax Rate: 0.0%
Equity: $956.82M
Total Debt: $2.39M
Cash: $52.33M
Tax Rate: 0.0%
Equity: $956.82M
Total Debt: $2.39M
Cash: $52.33M
Current Ratio (Can it pay short-term bills)
APICurrent Assets / Current Liabilities
39.04
Current Assets: $975.89M
Current Liabilities: $25.00M
Current Liabilities: $25.00M
Debt/Equity (Leverage — debt vs equity)
CALCTotal Debt / Total Equity
0.00
Short-Term Debt: $2.39M
Long-Term Debt: $0.00
Total Debt: $2.39M
Total Equity: $956.82M
Long-Term Debt: $0.00
Total Debt: $2.39M
Total Equity: $956.82M
Rev/Share (Top-line per share)
CALCRevenue / Shares Outstanding
$0.16
Revenue: $10.00M
Shares: 61,966,999
Shares: 61,966,999
Book Value/Share (Net assets per share)
CALC(Total Assets - Total Liabilities) / Shares
$15.44
Total Equity: $956.82M
Shares: 61,966,999
Shares: 61,966,999
FCF/Share (Real cash generated per share)
CALC(Operating Cash Flow + CapEx) / Shares
$-1.34
Operating CF: -$82.24M
CapEx: -$1.04M
Shares: 61,966,999
CapEx: -$1.04M
Shares: 61,966,999
CapEx is negative (outflow) — added to OCF to get FCF
Div Yield (Annual income from holding)
APILast Annual Dividend / Stock Price
0.0%
Last Dividend: N/A
Stock Price: $14.94
Stock Price: $14.94
Payout Ratio (Earnings paid out as dividends)
Dividends Paid / Net Income
—
Dividends Paid: N/A
Net Income: -$113.63M
Net Income: -$113.63M
Dividends paid not available in cash flow statement
Industry Benchmarks
Compares JANX against LLM-researched typical ranges for its
industry. One research call per industry, cached indefinitely — every stock in the same industry
reuses the same baseline.
Deep Analysis
Pre-flight intelligence scans the company first, then routes to the right analytical methods.
0
Company Classification
— What type of company is this?
1
Industry Landscape
— Where is the industry headed?
2
Company Momentum
— Where is this company trending?
3
Forward Projection
— 1Y & 2Y projected metrics (requires Layer 1 + 2)
4a
DCF Valuation
— Present value of future cash flows
4b
Earnings Power Value
— Floor value — worth with zero growth
4c
Anchored PE
— Industry PE adjusted for growth differential
4d
Reverse DCF
— What growth is the market pricing in?
4e
Revenue-Based DCF
— For growth/narrative companies (skip if mature earner)
4f
Anchored P/S
— Price-to-Sales peer comparison (skip if mature earner)
4g
Scenario Analysis
— Bull / Base / Bear (skip if mature earner)
4h
Dividend Discount Model
— For dividend/income stocks only
4i
Book Value Analysis
— For deep value / turnaround stocks only
4j
Insider Activity
— Are insiders buying or selling?
4f
Cash Flow Quality
— How trustworthy is the FCF?
4g
Debt Maturity Risk
— Can it handle its debt?
4h
Macro Environment
— Rates, market valuation, volatility
4i
Sector Intelligence
— How does this company compare within its sector?
4j
Revenue Confidence
— How reliable is the growth projection?
4k
Sensitivity Analysis
— How fragile is the fair value estimate?
4l
Sector Demand Cycle
— Is the sector in a boom, steady state, or contraction?
5
AI Investigation
— Adaptive research engine (Claude)
5b
Thesis Evaluation
— What does the market believe? (narrative/platform stocks only)
6
Valuation Synthesis
— Weighted verdict from all methods (requires Layer 4)
Income Statement (Annual)
Last updated: Jun 21, 2026 7:53pm (5d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $3.6M | $8.6M | $8.1M | $10.6M | $10.0M |
| Cost of Revenue | $26.2M | $841,000 | $2.0M | $2.1M | $2.0M |
| Gross Profit | -$22.6M | $7.8M | $6.1M | $8.5M | $8.0M |
| Operating Expenses | $10.3M | $74.9M | $79.1M | $107.4M | $165.6M |
| Operating Income | -$32.9M | -$67.1M | -$73.0M | -$98.8M | -$157.7M |
| Net Income | -$32.7M | -$63.1M | -$58.3M | -$69.0M | -$113.6M |
| EBITDA | -$32.6M | -$62.2M | -$56.3M | -$66.9M | -$111.6M |
| EPS | $-0.79 | $-1.52 | $-1.32 | $-1.28 | $-1.83 |
| EPS (Diluted) | — | — | — | — | — |
Balance Sheet (Annual)
Last updated: Jun 21, 2026 7:53pm (5d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $35.6M | $51.4M | $19.2M | $430.6M | $52.3M |
| Total Current Assets | $377.0M | $332.4M | $349.2M | $1.0B | $975.9M |
| Total Assets | $379.8M | $364.0M | $380.4M | $1.1B | $1.0B |
| Current Liabilities | $12.8M | $16.5M | $13.0M | $17.5M | $25.0M |
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $13.5M | $43.3M | $36.1M | $38.7M | $50.7M |
| Total Equity | $366.3M | $320.7M | $344.3M | $1.0B | $956.8M |
| Retained Earnings | -$47.4M | -$110.5M | -$168.8M | -$237.8M | -$351.4M |
Cash Flow (Annual)
Last updated: Jun 21, 2026 7:53pm (5d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | -$17.0M | -$42.9M | -$50.6M | -$43.8M | -$82.2M |
| Capital Expenditure | -$1.5M | -$6.4M | -$1.9M | $-359,000 | -$1.0M |
| Free Cash Flow | -$18.5M | -$49.4M | -$52.4M | -$44.2M | -$83.3M |
| Acquisitions (net) | $339.5M | -$64.7M | $0 | $0 | $0 |
| Debt Repayment | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — |
| Stock Buybacks | $0 | $0 | $0 | $0 | $-347,000 |
| Net Change in Cash | $28.6M | $15.8M | -$32.2M | $411.4M | -$378.3M |
Analyst Estimates (Annual)
Last updated: Jun 27, 2026 10:06am (just now)| Metric | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|
| Revenue |
$7.5M $4.5M – $10.5M
|
$18.7M $5.0M – $38.2M
|
$75.6M $20.1M – $154.2M
|
$161.6M $43.0M – $329.4M
|
| EBITDA |
-$7.5M -$10.5M – -$4.5M
|
-$18.7M -$38.2M – -$5.0M
|
-$75.6M -$154.2M – -$20.1M
|
-$161.6M -$329.4M – -$43.0M
|
| Net Income |
-$182.4M -$203.7M – -$109.8M
|
-$235.8M -$307.1M – -$122.5M
|
-$223.4M -$525.3M – -$10.3M
|
-$169.7M -$399.0M – -$7.8M
|
| EPS | — | — | — | — |
Growth Trends (YoY %)
Last updated: Jun 21, 2026 7:53pm (5d ago)| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue Growth | +136.8% | -6.1% | +31.0% | -5.6% |
| Gross Profit Growth | +134.4% | -21.1% | +39.2% | -6.5% |
| Operating Income Growth | -103.7% | -8.8% | -35.4% | -59.5% |
| Net Income Growth | -93.0% | +7.6% | -18.4% | -64.7% |
| EBITDA Growth | -91.1% | +9.5% | -18.8% | -66.7% |
Insider Trading (Recent)
Type codes
PPurchase
SSale
AAward / grant
MOption exercise
FIn-kind (tax)
CConversion
GGift
DReturn to issuer
All SEC Form 4 codes
Open market
- P Purchase
- Open-market or private purchase of shares.
- S Sale
- Open-market or private sale of shares.
Compensation (Rule 16b-3)
- A Award / grant
- Grant or award of securities (RSUs, options, etc.) under Rule 16b-3.
- D Return to issuer
- Securities disposed back to the company under Rule 16b-3.
- F In-kind (tax)
- Shares withheld or delivered to pay the option-exercise price or tax — not an open-market sale.
- I Discretionary
- Discretionary transaction under an employee plan — Rule 16b-3(f).
- M Option exercise
- Exercise or conversion of a derivative (option/RSU) into shares — exempt.
Derivatives
- C Conversion
- Conversion of a derivative security into the underlying shares.
- E Short expiration
- Expiration of a short derivative position.
- H Long expiration
- Expiration or cancellation of a long derivative position with value received.
- O OTM exercise
- Exercise of an out-of-the-money derivative.
- X ITM exercise
- Exercise of an in-the-money or at-the-money derivative.
Other exempt
- G Gift
- Bona fide gift of securities.
- L Small acquisition
- Small acquisition under Rule 16a-6.
- W Inheritance
- Acquisition or disposition by will or the laws of descent.
- Z Voting trust
- Deposit into or withdrawal from a voting trust.
Other
- J Other
- Other acquisition or disposition (explained in a Form 4 footnote).
- K Equity swap
- Transaction in an equity swap or similar instrument.
- U Tender / buyout
- Disposition via tender of shares in a change-of-control transaction.
Compensation-plan codes (A, D, F, M) are routine and rarely directional. Open-market P (buy) and S (sale) carry the most signal.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-06-11 | RA CAPITAL MANAGEMENT, L.P. | A-Award | 15,500.00 | $13.66 | $211,730 |
| 2026-06-11 | RA CAPITAL MANAGEMENT, L.P. | A-Award | 5,500.00 | $0.00 | $0 |
| 2026-06-11 | Simson Jake | A-Award | 15,500.00 | $13.66 | $211,730 |
| 2026-06-11 | Simson Jake | A-Award | 5,500.00 | $0.00 | $0 |
| 2026-06-11 | Kung Winston | A-Award | 15,500.00 | $13.66 | $211,730 |
| 2026-06-11 | Kung Winston | A-Award | 5,500.00 | $0.00 | $0 |
| 2026-06-11 | Hernday Natasha | A-Award | 15,500.00 | $13.66 | $211,730 |
| 2026-06-11 | Hernday Natasha | A-Award | 5,500.00 | $0.00 | $0 |
| 2026-06-11 | DOBMEIER ERIC | A-Award | 15,500.00 | $13.66 | $211,730 |
| 2026-06-11 | DOBMEIER ERIC | A-Award | 5,500.00 | $0.00 | $0 |
| 2026-06-11 | CAPPS VICKIE L | A-Award | 5,500.00 | $0.00 | $0 |
| 2026-06-11 | CAPPS VICKIE L | A-Award | 15,500.00 | $13.66 | $211,730 |
| 2026-06-11 | Barrett Ronald W | A-Award | 15,500.00 | $13.66 | $211,730 |
| 2026-06-11 | Barrett Ronald W | A-Award | 5,500.00 | $0.00 | $0 |
| 2026-06-02 | Doyle Janeen Noel | S-Sale | 4,059.00 | $14.03 | $56,944 |
| 2026-05-11 | Dobek Maria | S-Sale | 2,038.00 | $14.17 | $28,878 |
| 2026-02-02 | Go William | A-Award | 154,000.00 | $13.99 | $2.2M |
| 2026-02-02 | Go William | A-Award | 44,000.00 | $0.00 | $0 |
| 2026-01-26 | Go William | 0.00 | $0.00 | $0 | |
| 2026-01-02 | Meyer Andrew Hollman | S-Sale | 1,879.00 | $13.73 | $25,799 |
Narrative Economics
The story the market is telling about this stock — the intangible X-factor
(founder mythology, cult dynamics, TAM-of-imagination) that moves price beyond
what cash flows alone explain. After Shiller, Narrative Economics.
No narrative profile yet for JANX — it's generated by the pipeline (
market-narrative step).
No community reviews yet for JANX.
Be the first — hit How to Contribute, have any AI review this page, and paste its take back here.
My Notes
personal — only you see this
Sign in to save personal notes and rate your interest in this stock.
Data via Financial Modeling Prep · Cached for performance · fmp
v1.1.352 · d1100787 · 2026-06-26 11:39:30